Dupilumab Subcutaneous and Moxetumomab pasudotox-tdfk Intravenous
Determining the interaction of Dupilumab Subcutaneous and Moxetumomab pasudotox-tdfk Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Moxifloxacin
- Dupilumab Subcutaneous-Moxifloxacin (Systemic)
- Dupilumab Subcutaneous-Moxifloxacin Hydrochloride
- Dupilumab Subcutaneous-Moxifloxacin Injection
- Dupilumab Subcutaneous-Moxifloxacin Intravenous
- Dupilumab Subcutaneous-Moxifloxacin Tablets
- Moxetumomab pasudotox-tdfk Intravenous-Dupixent
- Moxetumomab pasudotox-tdfk Intravenous-Duplex T Topical
- Moxetumomab pasudotox-tdfk Intravenous-Durachol
- Moxetumomab pasudotox-tdfk Intravenous-Duraclon
- Moxetumomab pasudotox-tdfk Intravenous-Duraclon injection
- Moxetumomab pasudotox-tdfk Intravenous-Duraflu